| Type : |
Journal |
|
| Forskerhold : |
Vancouver - Children\'s and Women\'s Health Center of British Columbia |
| Forfattere : |
Ensom MHH, Decarie D, Sheppard I. |
| Titel : |
Stability of lansoprazole in extemporaneously compounded suspensions for nasogastric or oral administration. |
| Nummer : |
Can J Hosp Pharm ; 60, 3: 184-191. 2007 |
|
| Cotationvaleur : |
|
| Fysisk stabilitet : |
|
| Kemisk stabilitet : |
|
| Andre metoder : |
|
| Kommentarer : |
|
Lister
 Lansoprazole
|
 |
 |
 |
 |
150 mg
®=? (Abbott Laboratories) |
|
25°C |
 |
| 91 |
 |
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
25°C |
|
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
|
4°C |
 |
| 91 |
|
|
|
|
|
|
150 mg
®=? (Abbott Laboratories) |
| NaHCO3 8.4% |
25 ml |
| NaOH |
1N = 1.7 ml |
| OraPlus® / OraSweet® (1:1) |
23.3 ml |
| PH= |
8.4 |
|
4°C |
|
| 91 |
|
|
|
|
|
